semaglutide glp-1 medication How medications are transforming diabetes and weight loss treatment What are GLP-1 medications and

By 2017 revenue from liraglutide was US $843 million, and the overall market for GLP-1 drugs was growing 30 percent, up from just 3 percent in 2014 (Staton)

Because it was associated with excessive urine, ancient Greek physicians called the disease 'diabetes, which they took from the Greek word for 'siphon to reflect their observation that fluids flowed through diabetic patients like a siphon (Harris)

Research shows that GLP-1 medications can delay this weight loss plateau compared to diet alone, but eventually, most people will hit a wall

These include semaglutide (sold as Ozempic and Wegovy), tirzepatide (Mounjaro), liraglutide (Saxenda) and dulaglutide (Trulicity)

Boushey, R